nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—PTGS2—ovarian follicle—polycystic ovary syndrome	0.0856	0.315	CbGeAlD
Oxaprozin—CYP2C9—urine—polycystic ovary syndrome	0.041	0.151	CbGeAlD
Oxaprozin—Emotional distress—Metformin—polycystic ovary syndrome	0.0345	0.116	CcSEcCtD
Oxaprozin—Heartburn—Metformin—polycystic ovary syndrome	0.0213	0.0719	CcSEcCtD
Oxaprozin—Bifonazole—CYP17A1—polycystic ovary syndrome	0.0118	0.316	CrCbGaD
Oxaprozin—PTGS2—embryo—polycystic ovary syndrome	0.0116	0.0427	CbGeAlD
Oxaprozin—Renal impairment—Metformin—polycystic ovary syndrome	0.0112	0.0377	CcSEcCtD
Oxaprozin—Lethargy—Metformin—polycystic ovary syndrome	0.0109	0.0366	CcSEcCtD
Oxaprozin—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00972	0.0328	CcSEcCtD
Oxaprozin—PTGS2—adrenal cortex—polycystic ovary syndrome	0.00949	0.035	CbGeAlD
Oxaprozin—Pancreatitis—Metformin—polycystic ovary syndrome	0.00902	0.0304	CcSEcCtD
Oxaprozin—Sweating increased—Metformin—polycystic ovary syndrome	0.00896	0.0302	CcSEcCtD
Oxaprozin—PTGS1—endometrium—polycystic ovary syndrome	0.00886	0.0327	CbGeAlD
Oxaprozin—PTGS2—endometrium—polycystic ovary syndrome	0.00847	0.0312	CbGeAlD
Oxaprozin—Modafinil—ADRA1B—polycystic ovary syndrome	0.00842	0.226	CrCbGaD
Oxaprozin—Drowsiness—Metformin—polycystic ovary syndrome	0.00821	0.0277	CcSEcCtD
Oxaprozin—PTGS1—uterus—polycystic ovary syndrome	0.00817	0.0301	CbGeAlD
Oxaprozin—PTGS1—pituitary gland—polycystic ovary syndrome	0.00802	0.0296	CbGeAlD
Oxaprozin—PTGS1—adipose tissue—polycystic ovary syndrome	0.00799	0.0294	CbGeAlD
Oxaprozin—PTGS2—uterus—polycystic ovary syndrome	0.00781	0.0288	CbGeAlD
Oxaprozin—PTGS2—pituitary gland—polycystic ovary syndrome	0.00767	0.0282	CbGeAlD
Oxaprozin—PTGS2—adipose tissue—polycystic ovary syndrome	0.00764	0.0281	CbGeAlD
Oxaprozin—Hepatitis—Metformin—polycystic ovary syndrome	0.00737	0.0248	CcSEcCtD
Oxaprozin—PTGS1—adrenal gland—polycystic ovary syndrome	0.00717	0.0264	CbGeAlD
Oxaprozin—PTGS2—adrenal gland—polycystic ovary syndrome	0.00685	0.0252	CbGeAlD
Oxaprozin—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00681	0.0251	CbGeAlD
Oxaprozin—PTGS1—female gonad—polycystic ovary syndrome	0.00668	0.0246	CbGeAlD
Oxaprozin—PTGS1—vagina—polycystic ovary syndrome	0.00664	0.0245	CbGeAlD
Oxaprozin—PTGS2—female gonad—polycystic ovary syndrome	0.00639	0.0235	CbGeAlD
Oxaprozin—PTGS2—vagina—polycystic ovary syndrome	0.00635	0.0234	CbGeAlD
Oxaprozin—Flatulence—Metformin—polycystic ovary syndrome	0.00632	0.0213	CcSEcCtD
Oxaprozin—Dysgeusia—Metformin—polycystic ovary syndrome	0.00628	0.0212	CcSEcCtD
Oxaprozin—PTGS1—endocrine gland—polycystic ovary syndrome	0.00621	0.0229	CbGeAlD
Oxaprozin—Vision blurred—Metformin—polycystic ovary syndrome	0.00604	0.0204	CcSEcCtD
Oxaprozin—Tremor—Metformin—polycystic ovary syndrome	0.00601	0.0203	CcSEcCtD
Oxaprozin—Bifonazole—CYP19A1—polycystic ovary syndrome	0.00598	0.161	CrCbGaD
Oxaprozin—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00595	0.0201	CcSEcCtD
Oxaprozin—PTGS2—endocrine gland—polycystic ovary syndrome	0.00594	0.0219	CbGeAlD
Oxaprozin—Malaise—Metformin—polycystic ovary syndrome	0.00578	0.0195	CcSEcCtD
Oxaprozin—Syncope—Metformin—polycystic ovary syndrome	0.00575	0.0194	CcSEcCtD
Oxaprozin—Palpitations—Metformin—polycystic ovary syndrome	0.00567	0.0191	CcSEcCtD
Oxaprozin—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00564	0.019	CcSEcCtD
Oxaprozin—Hypertension—Metformin—polycystic ovary syndrome	0.00554	0.0187	CcSEcCtD
Oxaprozin—Discomfort—Metformin—polycystic ovary syndrome	0.00539	0.0182	CcSEcCtD
Oxaprozin—Oedema—Metformin—polycystic ovary syndrome	0.00523	0.0177	CcSEcCtD
Oxaprozin—Infection—Metformin—polycystic ovary syndrome	0.0052	0.0175	CcSEcCtD
Oxaprozin—Shock—Metformin—polycystic ovary syndrome	0.00515	0.0174	CcSEcCtD
Oxaprozin—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00512	0.0173	CcSEcCtD
Oxaprozin—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00506	0.0171	CcSEcCtD
Oxaprozin—Anorexia—Metformin—polycystic ovary syndrome	0.00499	0.0168	CcSEcCtD
Oxaprozin—Benzphetamine—ADRA1A—polycystic ovary syndrome	0.00491	0.132	CrCbGaD
Oxaprozin—Hypotension—Metformin—polycystic ovary syndrome	0.00489	0.0165	CcSEcCtD
Oxaprozin—Paraesthesia—Metformin—polycystic ovary syndrome	0.0047	0.0158	CcSEcCtD
Oxaprozin—Dyspnoea—Metformin—polycystic ovary syndrome	0.00467	0.0157	CcSEcCtD
Oxaprozin—Somnolence—Metformin—polycystic ovary syndrome	0.00465	0.0157	CcSEcCtD
Oxaprozin—Dyspepsia—Metformin—polycystic ovary syndrome	0.00461	0.0155	CcSEcCtD
Oxaprozin—Decreased appetite—Metformin—polycystic ovary syndrome	0.00455	0.0153	CcSEcCtD
Oxaprozin—Constipation—Metformin—polycystic ovary syndrome	0.00448	0.0151	CcSEcCtD
Oxaprozin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00431	0.0145	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00428	0.0144	CcSEcCtD
Oxaprozin—Urticaria—Metformin—polycystic ovary syndrome	0.00416	0.014	CcSEcCtD
Oxaprozin—Abdominal pain—Metformin—polycystic ovary syndrome	0.00414	0.014	CcSEcCtD
Oxaprozin—Asthenia—Metformin—polycystic ovary syndrome	0.00375	0.0127	CcSEcCtD
Oxaprozin—Pruritus—Metformin—polycystic ovary syndrome	0.0037	0.0125	CcSEcCtD
Oxaprozin—Diarrhoea—Metformin—polycystic ovary syndrome	0.00358	0.0121	CcSEcCtD
Oxaprozin—Warfarin—CYP1A1—polycystic ovary syndrome	0.00353	0.0948	CrCbGaD
Oxaprozin—Dizziness—Metformin—polycystic ovary syndrome	0.00346	0.0117	CcSEcCtD
Oxaprozin—Vomiting—Metformin—polycystic ovary syndrome	0.00333	0.0112	CcSEcCtD
Oxaprozin—Rash—Metformin—polycystic ovary syndrome	0.0033	0.0111	CcSEcCtD
Oxaprozin—Dermatitis—Metformin—polycystic ovary syndrome	0.0033	0.0111	CcSEcCtD
Oxaprozin—Headache—Metformin—polycystic ovary syndrome	0.00328	0.0111	CcSEcCtD
Oxaprozin—Nausea—Metformin—polycystic ovary syndrome	0.00311	0.0105	CcSEcCtD
Oxaprozin—Methadone—CYP19A1—polycystic ovary syndrome	0.00263	0.0708	CrCbGaD
Oxaprozin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—polycystic ovary syndrome	0.00227	0.00576	CbGpPWpGaD
Oxaprozin—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00227	0.00575	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.00222	0.00561	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—INSR—polycystic ovary syndrome	0.00221	0.0056	CbGpPWpGaD
Oxaprozin—CYP2C9—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00219	0.00554	CbGpPWpGaD
Oxaprozin—PTGS2—S1P1 pathway—VEGFA—polycystic ovary syndrome	0.00211	0.00534	CbGpPWpGaD
Oxaprozin—PTGS2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00207	0.00525	CbGpPWpGaD
Oxaprozin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.002	0.00507	CbGpPWpGaD
Oxaprozin—CYP2C9—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00198	0.005	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—CCNB1—polycystic ovary syndrome	0.00191	0.00485	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—PLAT—polycystic ovary syndrome	0.0019	0.00482	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00187	0.00475	CbGpPWpGaD
Oxaprozin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00186	0.00471	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00185	0.00469	CbGpPWpGaD
Oxaprozin—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00184	0.00465	CbGpPWpGaD
Oxaprozin—PTGS1—Overview of nanoparticle effects—IL6—polycystic ovary syndrome	0.00184	0.00465	CbGpPWpGaD
Oxaprozin—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00183	0.00464	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00176	0.00445	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—TAB1—polycystic ovary syndrome	0.00174	0.00441	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00164	0.00415	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00162	0.00411	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00159	0.00402	CbGpPWpGaD
Oxaprozin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—polycystic ovary syndrome	0.00157	0.00397	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.00155	0.00392	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00152	0.00386	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00151	0.00382	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.00147	0.00373	CbGpPWpGaD
Oxaprozin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00147	0.00373	CbGpPWpGaD
Oxaprozin—PTGS2—Overview of nanoparticle effects—IL6—polycystic ovary syndrome	0.00146	0.00369	CbGpPWpGaD
Oxaprozin—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00145	0.00368	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—NCOR1—polycystic ovary syndrome	0.00144	0.00366	CbGpPWpGaD
Oxaprozin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00141	0.00358	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00139	0.00353	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00139	0.00352	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00139	0.00352	CbGpPWpGaD
Oxaprozin—CYP2C9—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00137	0.00348	CbGpPWpGaD
Oxaprozin—PTGS1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00136	0.00346	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—NGFR—polycystic ovary syndrome	0.00133	0.00336	CbGpPWpGaD
Oxaprozin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—polycystic ovary syndrome	0.00124	0.00314	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.00123	0.00312	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.00123	0.00312	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00121	0.00305	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00119	0.00302	CbGpPWpGaD
Oxaprozin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00119	0.00301	CbGpPWpGaD
Oxaprozin—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00117	0.00297	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.00117	0.00296	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00116	0.00295	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.00113	0.00287	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.0011	0.00279	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.0011	0.00279	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.0011	0.00279	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.0011	0.00279	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00105	0.00266	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00104	0.00264	CbGpPWpGaD
Oxaprozin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.00104	0.00263	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.000978	0.00248	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000973	0.00246	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000972	0.00246	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000962	0.00244	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00096	0.00243	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000924	0.00234	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000923	0.00234	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—LEP—polycystic ovary syndrome	0.000906	0.00229	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.000899	0.00228	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000895	0.00227	CbGpPWpGaD
Oxaprozin—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000885	0.00224	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000876	0.00222	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000862	0.00218	CbGpPWpGaD
Oxaprozin—PTGS2—C-MYB transcription factor network—BCL2—polycystic ovary syndrome	0.000857	0.00217	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000857	0.00217	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000855	0.00217	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00085	0.00215	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000835	0.00212	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000816	0.00207	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NMNAT3—polycystic ovary syndrome	0.000811	0.00205	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000803	0.00203	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000801	0.00203	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000798	0.00202	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00079	0.002	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000782	0.00198	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SUOX—polycystic ovary syndrome	0.000782	0.00198	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000772	0.00196	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00073	0.00185	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00073	0.00185	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.00073	0.00185	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000727	0.00184	CbGpPWpGaD
Oxaprozin—PTGS1—Biological oxidations—POMC—polycystic ovary syndrome	0.000725	0.00184	CbGpPWpGaD
Oxaprozin—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000718	0.00182	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000711	0.0018	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00071	0.0018	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000679	0.00172	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000664	0.00168	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000648	0.00164	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000634	0.00161	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000633	0.0016	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00063	0.00159	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000625	0.00158	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000621	0.00157	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SUOX—polycystic ovary syndrome	0.000621	0.00157	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—TEAD2—polycystic ovary syndrome	0.000618	0.00157	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000618	0.00157	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000613	0.00155	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000612	0.00155	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000595	0.00151	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000585	0.00148	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00058	0.00147	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000577	0.00146	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000564	0.00143	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000553	0.0014	CbGpPWpGaD
Oxaprozin—PTGS1—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000539	0.00136	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000527	0.00133	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000518	0.00131	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000511	0.00129	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000509	0.00129	CbGpPWpGaD
Oxaprozin—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000504	0.00128	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.0005	0.00127	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000491	0.00124	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000491	0.00124	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—TEAD2—polycystic ovary syndrome	0.000491	0.00124	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000472	0.0012	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00047	0.00119	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—STAR—polycystic ovary syndrome	0.000469	0.00119	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000465	0.00118	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000463	0.00117	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.00045	0.00114	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000444	0.00113	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000429	0.00109	CbGpPWpGaD
Oxaprozin—PTGS2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000428	0.00108	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000419	0.00106	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—HMMR—polycystic ovary syndrome	0.000418	0.00106	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—RPL37A—polycystic ovary syndrome	0.000418	0.00106	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000411	0.00104	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000411	0.00104	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000411	0.00104	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000406	0.00103	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000398	0.00101	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—HMMR—polycystic ovary syndrome	0.000396	0.001	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000394	0.000997	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SRD5A1—polycystic ovary syndrome	0.00039	0.000988	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000382	0.000968	CbGpPWpGaD
Oxaprozin—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000381	0.000965	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000374	0.000946	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000373	0.000946	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—STAR—polycystic ovary syndrome	0.000372	0.000942	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000368	0.000931	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—LHB—polycystic ovary syndrome	0.000363	0.00092	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000355	0.000899	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000349	0.000883	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000344	0.000871	CbGpPWpGaD
Oxaprozin—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000338	0.000856	CbGpPWpGaD
Oxaprozin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000333	0.000842	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	0.000332	0.00084	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000331	0.000838	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	0.000326	0.000826	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000325	0.000823	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000325	0.000823	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000317	0.000802	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000316	0.000801	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000313	0.000792	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000313	0.000792	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000308	0.000779	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—RRM2—polycystic ovary syndrome	0.000307	0.000776	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—FGF18—polycystic ovary syndrome	0.000303	0.000766	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—RBP4—polycystic ovary syndrome	0.0003	0.00076	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000296	0.000751	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—YAP1—polycystic ovary syndrome	0.000296	0.000748	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—LHB—polycystic ovary syndrome	0.000288	0.000731	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NAMPT—polycystic ovary syndrome	0.000284	0.000719	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000282	0.000715	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000282	0.000714	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP11A1—polycystic ovary syndrome	0.00028	0.00071	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000278	0.000705	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—GAB1—polycystic ovary syndrome	0.000276	0.0007	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000273	0.000692	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000272	0.00069	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NAMPT—polycystic ovary syndrome	0.000269	0.000682	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000265	0.000671	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000261	0.00066	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000258	0.000654	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000251	0.000636	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	0.000251	0.000636	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	0.000247	0.000626	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.000246	0.000624	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000244	0.000617	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	0.000243	0.000616	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	0.000235	0.000594	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—TH—polycystic ovary syndrome	0.000226	0.000571	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	0.000225	0.000571	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000224	0.000567	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000223	0.000564	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000221	0.00056	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	0.00022	0.000556	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000219	0.000556	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	0.000212	0.000536	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	0.00021	0.000532	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000209	0.000531	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	0.000208	0.000527	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000207	0.000524	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000207	0.000524	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000206	0.000522	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—PRL—polycystic ovary syndrome	0.000198	0.000502	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000196	0.000497	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	0.000191	0.000484	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000187	0.000473	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	0.000184	0.000466	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000181	0.000458	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—TH—polycystic ovary syndrome	0.000179	0.000453	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	0.000175	0.000444	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000174	0.000441	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000166	0.000421	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000166	0.000421	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NCOR1—polycystic ovary syndrome	0.000166	0.000421	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000164	0.000415	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—NRG1—polycystic ovary syndrome	0.000163	0.000413	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	0.000161	0.000408	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	0.000155	0.000393	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	0.000155	0.000393	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	0.000149	0.000378	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000148	0.000376	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	0.000147	0.000373	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—MTHFR—polycystic ovary syndrome	0.000147	0.000372	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000146	0.000371	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	0.000146	0.00037	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IRS2—polycystic ovary syndrome	0.00014	0.000354	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	0.000139	0.000353	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000139	0.000353	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	0.000137	0.000347	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000132	0.000334	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	0.000126	0.000318	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—POMC—polycystic ovary syndrome	0.000124	0.000314	CbGpPWpGaD
Oxaprozin—PTGS1—Metabolism—INS—polycystic ovary syndrome	0.000123	0.000312	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	0.000123	0.000312	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IRS1—polycystic ovary syndrome	0.000122	0.000309	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—TH—polycystic ovary syndrome	0.000119	0.0003	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—INS—polycystic ovary syndrome	0.000117	0.000296	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	0.000115	0.000292	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—AKT2—polycystic ovary syndrome	0.000113	0.000286	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	0.000108	0.000275	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	0.000107	0.000272	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	9.98e-05	0.000253	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—POMC—polycystic ovary syndrome	9.84e-05	0.000249	CbGpPWpGaD
Oxaprozin—PTGS2—Metabolism—INS—polycystic ovary syndrome	9.79e-05	0.000248	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	9.68e-05	0.000245	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	9.22e-05	0.000234	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	8.74e-05	0.000221	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	8.15e-05	0.000206	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	6.61e-05	0.000167	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	6.52e-05	0.000165	CbGpPWpGaD
Oxaprozin—CYP2C9—Metabolism—INS—polycystic ovary syndrome	6.48e-05	0.000164	CbGpPWpGaD
Oxaprozin—PTGS2—Disease—IL6—polycystic ovary syndrome	5.11e-05	0.000129	CbGpPWpGaD
